Changes in Glycemic Control and Quality of Life in Pediatric Type 1 Diabetics with Continuous Subcutaneous Insulin Infusion of Insulin Aspart Following Multiple Daily Injection Therapy

The efficacy of continuous subcutaneous insulin infusion (CSII) of the rapid-acting insulin analogue, insulin aspart, was evaluated in 26 patients with childhood-onset type 1 diabetes aged between 6 and 18 yr who had been on basal-bolus therapy (multiple daily injection (MDI) of regular human insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Tomoyuki, Urakami, Tatsuhiko, Sugihara, Shigetaka, Kim, Hey Sook, Mochizuki, Mie, Amamiya, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2008
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004922/
https://www.ncbi.nlm.nih.gov/pubmed/24790361
http://dx.doi.org/10.1297/cpe.17.39

Ejemplares similares

Ejemplares similares